Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2015-01-08 10:27 (2771 d 04:26 ago) – Posting: # 14251
Views: 27,231

Dear Cher!

» Sorry to ask again, but I can't see any contradiction between point 1 and 3.

Once again slowly to take notes:
Suppose you have a subject with two periods absolved, in both Reference applied.
According to your rules, point 1, you don't have at least one Reference and one Test applied, so you will not include such a subject in the pharmacokinetic and statistical analysis.
Full stop.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
22,291 posts in 4,666 threads, 1,584 registered users;
online 10 (2 registered, 8 guests [including 5 identified bots]).
Forum time: Wednesday 15:54 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5